Market research
MLAB Mesa Laboratories Inc
NASDAQ USD Technology
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 685M
- P/E ratio
- 144.09
- Analyst target
- 125
- Dividend yield
- 0.5%
- Beta
- 1.05
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
- ISIN
- Not available
- Market cap
- 685M
- P/E ratio
- 144.09
- Analyst target
- 125
- Dividend yield
- 0.5%
- Beta
- 1.05
About
About Mesa Laboratories Inc
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Research context
Mesa Laboratories Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the MLAB discussion.
5 years, 7 months ago
Mesa Laboratories, Inc is currently in a long term uptrend where the price is trading 3.5% above its 200 day moving average.
From a valuation standpoint, the stock is 64.0% cheaper than other stocks from the Technology sector with a price to sales ratio of 9.1.
Mesa Laboratories, Inc's total revenue rose by 8.0% to $34M since the same quarter in the previous year.
Its net income has increased by 1.9% to $-5M since the same quarter in the previous year.
Finally, its free cash flow grew by 0.7% to $11M since the same quarter in the previous year.
Based on the above factors, Mesa Laboratories, Inc gets an overall score of 5/5.